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Abstract
Human enterovirus 71 (EV71) is a member of the Enterovirus genus of the Picornaviridae family. Other members of this family utilize
an unusual mechanism of translation initiation whereby ribosomes are recruited internally to the viral RNA by an internal ribosome site
(IRES) located in their 5 noncoding regions (5 NCR). Using dicistronic reporter constructs, we demonstrate that the 5 NCRs of the
7423/MS/87 and BrCr strains of EV71 function as an IRES both in extracts and in cultured cells. Preincubation of translation extracts with
purified coxsackievirus 2A protease cleaved elF4G, a component of the cap binding complex, resulting in a significant decrease in translation
of capped mRNAs. In contrast, the translational efficiency of the EV71 IRES was enhanced under this condition, demonstrating that the
EV71 IRES functions similar to other enterovirus IRES elements when components of the cap binding protein complex are cleaved. Finally,
insertion of an upstream, out-of-frame start codon in the 5 NCR of the EV71 genome inhibited IRES activity, suggesting that EV71 can
be classified as a type I IRES, in which ribosomes first bind upstream of the initiation codon and then scan the mRNA until an appropriate
downstream AUG start codon is encountered and protein synthesis commences.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Enterovirus 71 (EV71) has been implicated in numerous
epidemics of hand, foot, and mouth disease (HFMD), pri-
marily infecting young children and infants. In a few cases,
more serious symptoms develop such as polio-like paraly-
sis, encephalitis, and meningitis, sometimes even resulting
in death (reviewed in McMinn, 2002). Since its identifica-
tion in 1969, outbreaks of EV71 have been reported in the
United States, Australia, Europe, and Asia (McMinn, 2002).
EV71 belongs to the human Enterovirus genus of the Pi-
cornaviridae family. The nucleotide sequence of EV71 is
77% identical to Coxsackievirus A16 (CA16) (Brown and
Pallansch, 1995). In fact, the clinical symptorns of HFMD
for both of these viruses are indistinguishable; however,
infection with CA16 rarely results in neurological diseases
or death (McMinn, 2002). Currently, there is no treatment or
vaccine against EV71. Thus, molecular events that underlie
EV71 gene amplification are under intense scrutiny.
EV71 is a nonenveloped virus that contains a single, posi-
tive-stranded RNA genome, approximately 7500 nucleotides
in length (Brown and Pallansch, 1995). Similar to in all picor-
naviral RNAs, the EV71 genome encodes a single polypeptide
that is processed by viral proteinases to yield the viral structural
and nonstructural proteins (Brown and Pallansch, 1995). Based
upon the sequence organization, synthesis of the EV71
polyprotein has been postulated to be mediated by an internal
ribosome entry site (IRES) element that can directly recruit
ribosomes to the viral mRNA (McMinn, 2002). The purpose of
this study was to test this hypothesis and to determine the type
of IRES that may be present.
Dependent on the location of the IRES in relation to the
AUG start codon, IRES elements can be divided into three
types: entero- and rhinoviruses (type I), cardio- and aphtho-
viruses (type II), and hepatitis A virus (type III) (Hellen and
Wimmer, 1995; Jackson et al., 1990; Jang et al., 1990;
Wimmer et al., 1993). Each type can be distinguished func-
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tionally. For example, type I IRESs function poorly and type
III IRESs function not at all in the rabbit reticulocyte lysate
(RRL). In contrast, type II IRESs efficiently mediate transla-
tion initiation in the RRL. Mechanistically, type II and type III
IRESs encompass the start site AUG codon, while type I
IRESs reside 30 to 150 nucleotides upstream of the start codon.
Thus, translation initiation mediated by a type I IRES involves
internal ribosome binding, followed by ribosome scanning of
the mRNA to identify an appropriate downstream start site
AUG codon (Hellen and Sarnow, 2001).
During viral infection, enteroviruses express a viral pro-
teinase, 2A, that cleaves the translation initiation factor
eIF4G, which is part of the elF4F cap recognition complex
required for cap-dependent translation. This is just one of
several steps by which these viruses subvert the host cell
translation machinery. Importantly, it is known that the
cleaved products of elF4G can stimulate the activities of
type I but not type II viral IRES elements (Borman et al.,
1995; Hambidge and Sarnow, 1992).
In this study, we examined the translation of dicistronic
reporter mRNAs that contained the EV71 5 noncoding
region (NCR) in the intercistronic spacer region in both
human and monkey cells, demonstrating that the EV71 5
NCR contains an IRES. It was found that the EV71 IRES
functionally resembles the polioviral IRES, because cleav-
age of eIF4G by coxsackieviral proteinase 2A resulted in
enhanced IRES activity. In addition, insertion of an up-
stream start codon abrogated IRES activity, demonstrating
that the mechanism of initiation by the EV71 IRES involves
a scanning process characteristic of a type I IRES.
Results
The 5 NCRs of two EV71 strains have IRES activity
cDNA copies of the 5 NCRs from EV71 BrCr and
7423/MS/87 strains were obtained using total RNA from
virus-infected cells (a generous gift from Betty A. Brown,
Centers for Disease Control and Prevention, Atlanta, GA) as
the source of viral RNA in a 5 RACE amplification reac-
tion. Sequence determination of several cDNAs from each
strain revealed several nucleotide changes from the pub-
lished sequences (GenBank Accession Nos.: U22521,
U22522) (Brown and Pallansch, 1995). However, all nucle-
otide changes preserved predicted base pairings and, there-
fore, most likely do not affect the structures of the 5 NCRs
(Fig. 1A). One cDNA of the EV71 BrCr 5 NCRs contained
additional mutations at nucleotide positions 47 (C47U) and
283 (G283A) (Fig. 1A, black arrowheads), which were not
found in any of the other isolates and will be referred to as
BrCr variant. Although we cannot rule out that these nucle-
otide changes were introduced during the cDNA synthesis
step, the conservation of predicted helical structures seems
to indicate that at least some of these changes were present
in the population of EV71 RNA in infected cells.
The BrCr wild-type and variant 5 NCRs were inserted
into the intercistronic spacer region of a dicistronic reporter
that can be transcribed by RNA polymerase II to yield
capped dicistronic mRNAs (Fig. 1B). Supercoiled plasmid
DNA was transfected into human tet HeLa cells and trans-
fected RNA and enzymatic luciferase activities were exam-
ined. To examine the integrity of the dicistronic mRNAs,
the size of expressed poly(A)-containing mRNA was exam-
ined in Northern blots. Fig. 1C demonstrates that only
full-length dicistronic reporter mRNAs were produced for
the EMCV, , BrCr wild-type, and BrCr variant mRNAs
(Fig. 1C, lanes 1 through 4). In contrast, cells transfected
with a dicistronic mRNA containing the 7423/MS/87 5
NCR in the intercistronic spacer region gave rise to shorter
RNA species, most likely caused by the presence of a
cryptic promoter in the 7423/MS/87 5 NCR (Fig. 1C, lane
5). Therefore, a putative IRES activity of the 7423/MS/87
sequence could not be monitored in this assay.
Next, the translation of the dicistronic mRNA was ex-
amined. Translation of the Renilla luciferase was expected
to be initiated by a cap-dependent scanning and was there-
fore used to normalize for transfection efficiency. The Re-
nilla luciferase activities were comparable for each reporter
construct in individual experiments. The encephalomyocar-
ditis virus (EMCV) IRES, shown previously to promote
internal initiation, served as a positive control. Insertion of
the EV71 BrCr wild-type and variant 5 NCR sequences
into the dicistronic reporter greatly enhanced the production
of firefly luciferase (Fig. 1D) greater than that observed with
the EMCV IRES, suggesting that these sequences mediate
IRES activity. To more rigorously examine the possibility
that nonspecific or cryptic transcription initiation by RNA
polymerase II resulted in the generation of monocistronic
firefly luciferase mRNAs, promoterless dicistronic reporters
were transfected into HeLa cells and Renilla and firefly
luciferase activities were measured. With the exception of
the EV71 7423/MS/87 construct, none of the constructs
expressed Renilla or luciferase activities (data not shown).
However, the EV71 7423/MS/87 5 NCR, inserted into the
dicistronic promoterless reporter, mediated the synthesis of
firefly luciferase (data not shown). This result supports the
hypothesis that the EV71 7423/MS/87 5 NCR contains a
cryptic promoter activity which can generate monocistronic
mRNAs. Thus another approach was required to assess the
presence of an IRES in the 7423/MS/87 5 NCR.
In a second assay for potential IRES activity in EV71
RNAs, capped dicistronic reporter mRNAs were generated
by in vitro transcription (Fig. 2A). Full-length RNAs (Fig.
2B) were transfected into COS cells which can be efficiently
transfected with RNA molecules. Fig. 2C shows that the
BrCr wild-type, BrCr variant, and EV71 7423/MS/87 5
NCRs all functioned as IRESs. Importantly, the IRES ac-
tivity observed for the BrCr wild-type 5 NCR was similar
in both the RNA and the DNA transfection assays (compare
Fig. 2C with 1D). Interestingly, the BrCr variant 5 NCR
consistently demonstrated lower IRES activity than the
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BrCr wild-type sequence. One of the mutations, C47U,
converts a GC base pair to a GU base pair; the other
mutation, 283 (G to an A), resides in a bulge region of
domain IV in the predicted structure (Fig. 1A, black arrow-
heads). At present, it is not known which of those nucleotide
changes correlates with the BrCr variant IRES activity.
Cleavage of eIF4GI enhances EV71 IRES activity in vitro
To examine the effect of cleavage of elF4G by proteinase
2A on EV71 IRES activity, translational activities of vari-
ous capped dicistronic reporter RNAs were measured in
translationally competent extracts made from suspension
HeLa cells. The IRES activities of the various EV71 IRESs
were very similar to the activities observed in cultured cells
(Fig. 3A). To assess the requirement for eIF4G on the EV71
IRES activity, the translation extract was preincubated with
purified coxsackievirus proteinase 2A. Efficient cleavage of
eIF4GI was monitored by Western blot (Fig. 3B). Addition
of 25 or 250 ng of purified protease 2A resulted in complete
cleavage of full-length eIF4GI. As expected, the translation
of the first cistron in dicistronic reporter RNAs, which
contained the EV71 7423/MS/87 IRES, decreased signifi-
cantly in extracts preincubated with either 25 or 250 ng of
proteinase 2A (Fig. 3C, see Renilla luciferase activity). In
contrast, IRES-mediated translation of the second cistron
increased in proteinase 2A treated extracts (Fig. 3C, see
firefly luciferase activity). This result demonstrates that the
EV71 IRES, similar to the poliovirus, rhinovirus, and cox-
sackievirus IRES elements, does not require intact eIF4GI
for its activity. The observed stimulation could result from
an increase in available 40S subunits, trans-activation of
IRES activity by cleaved eIF4GI, or both.
EV71 is a type I IRES
Preliminary translation studies in the RRL suggested
that the EV71 is a type I IRES. Specifically, the EV71
IRES mediated translation of the second cistron in a dicistronic
Fig. 1. The enterovirus 71 BrCr 5NCR has IRES activity. (A) Diagram of the
predicted secondary structure of the EV71 5NCR (http://www.personal.
uni-jena.de/i6zero/ev71brcr.html). Variations in nucleotide sequence from
previously published sequences are indicated: black arrows locate the
positions of U27C and U352C changes in 7423/MS/8727; gray arrowheads
indicate the C28U and U36C changes in BrCr; and black arrowheads
indicate C47U and G283A changes in a single clone of BrCr, termed BrCr
variant. (B) Diagram of the dicistronic reporter mRNA whose expression
is directed by the CMV promoter. The highly structured  sequences
(Carter and Sarnow, 2000) are present in all the reporters upstream of the
viral 5 NCR sequences and serve to prevent readthrough of ribosomes to
the downstream coding region. (C) Northern blot of poly(A)-selected
mRNA isolated from tet HeLa cells transfected with supercoiled plasmid
DNA containing the 5 NCRs of EMCV (lane 1),  (lane 2), BrCr
wild-type (lane 3), BrCr variant (lane 4), and 7423/MS/87 (lane 5) inserted
into the dicistronic reporter. The hybridization probe is complementary to
the firefly luciferase open reading frame. (D) IRES activity in transiently
transfected tet HeLa cells. Each transfection was performed in triplicate.
The firefly luciferase activity was normalized to the Renilla luciferase
activity for each transfection. Error bars indicate the standard deviation.
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mRNA with an efficiency that was only two- to three-fold over
the control mRNA lacking an IRES (data not shown). This
result was in contrast to the findings obtained in the HeLa
translation lysate where the EV71 IRES mediated a 150-fold
enhanced production of luciferase compared to control
mRNAs lacking the viral IRES (Fig. 3A).
To distinguish more rigorously whether the EV71 IRES
was a type I or a type II IRES, a start-site AUG codon, out
of frame with the firefly luciferase reading frame, was gen-
erated by site-directed mutagenesis 47 nucleotides upstream
of the coding region (Fig. 4A). If the EV71 5 NCR func-
tions as a type II IRES, ribosomes should bind directly at the
AUG codon of firefly luciferase and remain unaffected by
the presence of the upstream AUG codon. In contrast, if the
EV71 IRES functions similar to a type I IRES, the intro-
duced AUG codon is predicted to serve as start codon
resulting in the synthesis of a short peptide (Fig. 4A) and
little or no firefly luciferase should be produced. In vitro
transcribed capped RNAs (Fig. 4A) were transfected into
Cos cells and translation was assessed by measuring lucif-
erase activity. Results from translation assays shown in Fig.
4B argue that the EV71 is a type I IRES, because introduc-
tion of the out-of-frame upstream AUG dramatically de-
creased firefly luciferase activity. Importantly, introduction
of a UAG stop codon at the same position yielded the same
luciferase activity as the wild-type BrCr IRES, suggesting
that loss of IRES activity by the AUG codon was unlikely
due to structural changes in the RNA.
Discussion
One of the hallmarks of the picornavirus family is the
initiation of protein synthesis by internal initiation (Hellen and
Sarnow, 2001). Our analysis of the EV71 5 NCR indicates
that it does indeed contain an IRES element. Using classical
dicistronic reporter assays, we have demonstrated that the
EV71 5 NCR initiates translation internally by a cap-indepen-
dent mechanism. IRES activity was detected both in cultured
cells and in translation-competent extracts from human HeLa
cells.
Three lines of evidence have suggested that the EV71 can
be classified as a type I IRES. First, the EV71 IRES functioned
in cultured cells and in translation-competent S10 extracts,
approximately 150 times more efficiently than a control se-
quence, i.e., no insert in the intergenic region, as shown in Fig.
3A. In contrast, the EV71 IRES functioned only poorly in the
RRL, resulting in a threefold translational enhancement over a
control (data not shown). This finding is characteristic of type
I IRES elements which require additional cellular factors that
are lacking in RRL (Borman and Jackson, 1992; Dorner et al.,
1984; Svitkin et al., 1988). Second, preincubation of the HeLa
cell extracts with the protease 2A, which cleaves eIF4GI,
resulted in a decrease in cap-dependent translation and an
increase in translation of the reporter gene linked to the EV71
BrCr 5 NCR, again suggesting that this IRES utilizes a cap-
independent mechanism of translation initiation which is char-
acteristic of a type I IRES (Hambidge and Sarnow, 1992;
Liebig et al., 1993; Ziegler et al., 1995), and not of a type II
IRES which is not enhanced by protease 2A (Ziegler et al.,
1995). Third, insertion of an out-of-frame AUG codon up-
stream of the AUG start-codon of the firefly luciferase resulted
in reduction of luciferase activity, indicating that ribosome
associated upstream of the firefly luciferase open reading frame
and commenced protein synthesis at the inserted upstream
AUG. Importantly, insertion of a stop codon UAG at the same
position had no effect on firefly luciferase activity, suggesting
that a secondary structure was not disturbed by the base
changes at this position. Again, start-site AUG codon recog-
Fig. 2. Transfection of dicistronic reporter RNAs demonstrates that the 5
NCRs of 7423/MS/87 and BrCr strains of EV71 contain IRES activity. (A)
Diagram of the dicistronic reporter RNA. (B) Denaturing agarose gel
displaying in vitro transcribed RNA. Gibco-BRL 0.24–9.5 kb RNA mark-
ers (lane 1) were used to verify that full-length RNAs were generated for
7423/MS/87 (lane 2), BrCr wild-type (lane 3), BrCr variant (lane 4), 
(lane 5), and EMCV (lane 6). RNAs were detected after staining with
ethidium bromide. (C) In vitro transcribed, capped, dicistronic RNAs were
transfected into Cos cells (n  6). Firefly luciferase activity was normal-
ized to Renilla luciferase activity for each transfection. All IRES activities
are graphed relative to the positive control EMCV (100%). Error bars
shown for the transfections into Cos cells indicate standard deviation.
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nition by internal ribosome binding following scanning is char-
acteristic of type I IRES elements.
Genetically, EV71 is most closely related to the enterovirus
CA16, a common cause of HFMD. While EV71 is commonly
associated with this disease, CA16 has not been associated
with diseases of the central nervous system such as paralysis,
aseptic meningitis, and encephalitis. The only other enterovirus
to which such symptoms have been attributed is poliovirus.
Molecular genetic studies of poliovirus virulence has shown
that minor sequence variations in the 5UTR and the VP1 gene
are sufficient to account for large differences in neurovirulence
(Gromeier et al., 1999; McMinn, 2002). Genetic differences
between the nonneurovirulent CA16, or even the less neuro-
virulent strains of EV71, and the most neurovirulent stains
revealed too many nucleotide differences to identify a potential
neurovirulent determinant based on sequences alone (McMinn,
2002). However, a single neurovirulence determinant has been
tentatively located in the VP1 coding sequence, based upon its
high prevalence in the Perth C2 group of EV71 viruses, which
display a high frequency of neurovirulence (Brown et al.,
1999). Specifically, a single amino acid substitution in VP1
(A170V) was identified that is predicted to affect virus-recep-
tor interactions (McMinn, 2002). However intriguing, the ef-
fect of this amino acid substitution on neurovirulence has not
been shown. For EV71, whose pathology manifests in similar
ways to poliovirus, the study of the 5 NCR may be informa-
tive for understanding the molecular basis of the diseases it
causes. Furthermore, the EV71 IRES offers a potential target
for antiviral agents that reduce the severity of neurological
disease.
Materials and methods
Cloning and sequencing the EV71 5 NCRs
The prototype strain of EV71, BrCr, was originally iso-
lated from an 18-month-old child who displayed paralytic
illness; the 7423/MS/87 strain was obtained from a
2-month-old child who showed signs of aseptic meningitis
(Brown and Pallansch, 1995). A total pool of RNA from
infected cells was used as a source of viral RNA. The 5
RACE System for Rapid Amplification of cDNA Ends
Version 2.0 (Invitrogen Life Technologies) was performed
to clone the 5 NCRs of EV71, essentially as described by
the manufacturer’s protocol for high G:C content RNA.
Briefly, total RNA from human lung fibroblast cells infected
with EV71 BrCr or 7423/MS/87 (a generous gift from Betty
A. Brown, Centers for Disease Control and Prevention, At-
lanta, GA) was used to generate first-strand cDNA using either
GSP1 BrCr, 5GTGGAGCCTTCCGTGGCTGA3, or GSP1
MS, 5GAATTCTCGTGGGAGCCGGA3 primer. Primers
were annealed to total RNA at 70°C for 10 min and transferred
to 50°C. A 50-l reverse transcription reaction was performed
at 50°C for 50 min in 20 mM Tris–HCI pH 8.4, 50 mM KCI,
2.5 mM MgCl2, 0.5 mM each dNTP, 10 mM DTT, 200 units
Fig. 3. EV71 does not require intact eIF4G for translation. (A) In vitro
transcribed capped RNAs containing either EMCV, BrCr wild-type, BrCr
variant, 7423/MS/87 IRESs or nothing () inserted into the dicistronic
reporter were translated in vitro in a HeLa S10 extract for 30 min at 30°C.
Renilla and firefly luciferase activities were measured, and firefly luciferase
was normalized to Renilla activity. Error bars indicate the high and low
values for duplicate experiments. (B) Immunoblot of HeLa S10 extracts
preincubated with purified coxsackievirus protease 2A for 20 min at 30°C.
Eight micrograms of protein was separated by SDS–PAGE and immuno-
blotted with antibodies directed against eIF4GI. (C) Translational activities
of the first, cap-dependent, cistron and the second, IRES-dependent, cistron
of 7423/MS/87 IRES in HeLa S10 translation extract preincubated with 0,
25, or 250 ng of protease 2A. Error bars indicated the high and low for the
duplicate experiments.
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of SuperScript II RT, 2 g total RNA, 100 nM GSP1 primer.
The reaction was terminated at 70°C for 15 min and chilled on
ice. The RNA was degraded using 1 l RNase mix (RNase H
and RNase T1) at 37°C for 30 min and the cDNA was purified
by adding 225 l binding solution (6 M Nal) before applying
it to a GLASSMAX DNA Isolation Spin Cartridge (Invitrogen
Life Technologies). One-fifth of the cDNA was used for dC-
tailing in 10 mM Tris–HCI pH 8.4, 25 mM KCI, 1.5 mM
MgCl2, 200 M dCTP, and 0.4 U/l of terminal deoxynucle-
otidyltransferase; reaction was incubated for 1 h on ice and
heat inactivated at 65°C for 10 min, before applying it to a
GLASSMAX DNA Isolation Spin Cartridge (Invitrogen Life
Technologies). One-tenth of the dC-tailed cDNA product was
used for PCR amplification in reaction mixtures containing 20
mM Tris–HCI pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 400 nM
Abridged Anchor Primer 5GGCCACGCGTCGACTAG-
TACGGGIIGGGIIGGGIIG 3, 200 M of each dNTP, 400
nM nested GSP2 primer, and 0.5 U/l Taq DNA polymerase
(Promega, Madison, WI). For EV71 BrCr and 7423/MS/87
strains the nested GSP2 primers were 5CTGGGAGCCCAT-
GGCTTCGTGTTC3 and 5GTGAACCCATGGTCAACT-
GTATTGAG 3, respectively. Amplification reactions were
performed under the following conditions: tubes were trans-
ferred from ice directly to 94°C for 2 min followed by 35
cycles at 94°C for 45 s, 55°C for 45 s, and 72°C for 90 s; finally
a final extension was performed at 72°C for 7 min. The PCR
product was gel isolated on a 0.8% agarose gel and purified
using Qiaex II agarose gel extraction columns (Qiagen). Am-
plification of 2% of the gel purified product was performed
using the respective nested GSP2 primers and primers specific
to the 5 ends of either EV71 BrCr 5CCAAAAGAATTCT-
TAAAACAGCTGTGGGTTGTCACCC3 or EV71 7423/
MS/87 5CCAAAAGAATTCTTAAAACAGCTGTGGGTT-
GTTCCCA3 using the Advantage 2 PCR polymerase mix
Fig. 4. Introduction of an upstream out-of-frame start codon as a test for type I IRES activity. (A) Diagram of the EV71 BrCr 5 NCRs with either an upstream
out-of-frame start codon (BrCr AUG) or a stop codon (BrCr UAG). The nucleotide changes that differ from wild-type are underlined. Boxes indicate the open
reading frames. (B) Translational activities of the second cistron for each of the indicated constructs. In vitro transcribed capped RNAs containing either
EMCV, BrCr wild-type, BrCr AUG, or BrCr UAG or nothing () inserted into the dicistronic reporter were transfected into Cos cells. For each transfection
the firefly luciferase measurements were normalized to the Renilla luciferase measurements. The ratio is indicated relative to the EMCV positive control,
defined as 100%. Error bars indicate the standard deviation for four replicate experiments.
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(Clontech, Palo Alto, CA), precisely as described by the man-
ufacturer. A single PCR product of the expected size was
generated and cloned into the pCR2.1 vector (Invitrogen Life
Technologies). Several clones of PCR2.1 BrCr and PCR2.1
7423/MS/87 were sequenced by the PAN facility at Stanford
University (Stanford, CA).
Construction of dicistronic luciferase reporter constructs
To generate dicistronic pBrCr wild-type, pBrCr variant,
and p7423/MS/87 plasmids, the plasmids were digested
with NcoI and EcoRI. Note that the pCR2.1 7423/MS/87
plasmid was partially digested with NcaI, because the 5
NCR contains an internal NcoI site. The fragments contain-
ing the 5 NCRs were subcloned into the intercistronic
region of a dicistronic luciferase reporter construct in which
transcription is directed by the human cytomegalovirus pro-
moter, pEMCV, as described previously (Carter and Sar-
now, 2000). The plasmids designated as  in the text are
pEMCV vectors with no insert. The constructs using
EMCV in the intercistronic region, pEMCV, contain the
full-length EMCV 5 NCR between the EcoRI and NcoI
sites, as described (Carter and Sarnow, 2000).
To generate in vitro transcripts, a cassette of the
dicistronic reporters were inserted into the pRDEF
plasmid (Johannes et al., 1999) containing a T7 pro-
moter. Briefly, the EcoRI to XbaI fragment containing
the 5 NCR linked to firefly luciferase was inserted
into the EcoRI and XbaI site of pRDEF to gener-
ate T7BrCrwild-type, T7BrCrvariant, T77423/MS/87,
T7EMCV, and T7 plasmids. QuickChange XL (Strat-
agene) was used, as described by the manufacturer, to generate
the T7BrCrAUG plasmid, using oligos 5GTTGGATTCA-
CACCTCTCACCATGGAAACGTTACACACCCTC3 and
5GAGGGTGTGTAACGTTTCCATGGTGAGAGGTGT-
GAATCCAAC3 and the T7BrCrwild-type plasmid as tem-
plate. Plasmid T7BrCrUAG was generated the same way,
using 5GTTGGATTCACACCTCTCACCTAGGAA-
ACGTTACACACCCTC3 and 5GAGGGTGTGTA-
ACGTTTCCTAGGTGAGAGGTGTGAATCCAAC3 oligos
and T7BrCrAUG as a template.
In vitro RNA synthesis
Capped RNA transcripts were synthesized from
T7BrCrwild-type, T7BrCrvariant, T77423/MS/87, T7EMCV,
T7, T7BrCrAUG, and T7BrCrTAG plasmids linearized with
BamHI. Briefly, 5 g of linearized plasmid DNA was incu-
bated for 4 h at 37°C in 80 mM HEPES-KOH pH 7.5, 12 mM
MgCl2, 2 mM spermidine, 40 mM dithiothreitol, 100 units
RNasin (Promega), 1.5 mM m7 GpppG (New England Bio-
labs), 0.3 mM GTP, 40 mM CTP, 40 mM UTP, 40 mM ATP,
2.5 units yeast inorganic pyrophosphatase (Sigma), and 10
g/ml T7 RNA polymerase (gift from B. Burnett, University
of Colorado Health Sciences Center). Then, the DNA template
was digested with 3 units of DNase RQ1 at 37°C for 15 min.
The RNA transcripts were extracted with 5:1 phenol/chloro-
form, pH 5 (Amersco, Solon, OH). The aqueous phase was
placed over a G-25 Sephadex (Sigma) column to remove
unincorporated nucleotides. The RNA was precipitated with
0.3 M sodium acetate pH 5.2 and 3 volumes 100% ethanol.
The RNA pellet was washed with 70% ethanol and resus-
pended in RNase-free H2O. Integrity of the RNAs was mon-
itored by electrophoresis in a 16% formaldehyde denaturing
0.8% agarose gel. RNA concentrations were determined spec-
trophotometrically.
DNA and RNA transfections
For DNA transfections, tet-HeLa cells (Clontech) were
plated at 4  105 cells per 60-mm plate and transfected 18
to 24 h later with 3 g of supercoiled plasmid DNA and 12
l of Lipofectin reagent (Invitrogen Life Technologies)
according to the manufacturer’s directions. Serum-contain-
ing medium was added after 24 h, and extracts were pre-
pared after 48 h. For RNA transfections human tet-HeLa
(Clontech) or monkey COS cells were plated at 4  105 or
2  105 cells per 60-mm plate, respectively. Cells were
transfected 18 to 24 h later with 800 ng RNA in the presence
of 20 units RNasin, 160 M dithiothreitol, 20 l Lipofectin
reagent (Invitrogen Life Technologies) in phosphate-buff-
ered saline (Novak et al., 1996). The cells were transfected
for 10 min at room temperature; the transfection mix was
replaced with Dulbecco’s modified Eagle’s medium supple-
mented with 10% (v/v) fetal calf serum and 1% (v/v) pen-
icillin/streptomycin (Invitrogen Life Technologies). Ex-
tracts were prepared from RNA-transfected cells after 4 h
incubation at 37°C.
Dual luciferase assay
Cells from a 60-mm plate were washed with phosphate-
buffered saline and lysed for 15 min on an orbital shaker
with 0.5 ml passive lysis buffer (Promega). Lysed cells were
transferred to a microfuge tube and cellular debris was
removed by sedimentation. Two microliters of supernatant
was assayed for 15 s using the Dual Luciferase Reporter
Assay System (Promega) according to the manufacturer’s
directions.
Northern analysis
Total RNA was isolated using TRIzol (Invitrogen Life
Technologies) according to the manufacturer’s directions.
Polyadenosine-containing (poly(A)) RNA was purified
from the total RNA using Oligotex (Qiagen) according to
the manufacturer’s protocol; 2.5 g of poly(A)-selected
RNA was separated on a denaturing agarose gel (12%
formaldehyde, 0.8% agarose, 1X MOPS buffer) and trans-
ferred to a Zeta-Probe membrane (Bio-Rad). A DNA seg-
ment of the firefly luciferase coding region was generated
by PCR, containing pEMCV and 5GCGTGAGATTCTC-
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GCATGCC3 and 5CCCAGTAAGCTATGTCTCCAG3
oligos. The gel-purified PCR product was radiolabeled us-
ing the RadPrime kit (Invitrogen Life Technologies). The
Northern blots were hybridized in ExpressHyb (Clontech)
to the 32P-labeled DNA probe. Northern blots were ana-
lyzed by autoradiography.
Immunoblot analysis
Approximately 8 g of protein from HeLa S10 extracts
was separated by SDS–PAGE and transferred to Immo-
bilon-P (Millipore), and antibodies directed against elF4GI
were used to visualize intact and cleaved elF4G. Immuno-
blots were developed using an ECL kit (Amersham Phar-
macia), as directed by the manufacturer.
HeLa S10 translation assays
HeLa S10 translation extracts were prepared as described
previously (McBratney and Sarnow, 1996). In vitro trans-
lation was performed using 100 ng RNA and 17.5% (v/v)
S10 HeLa cell extract; this condition was determined to be
in the linear range for both cap-dependent and cap-indepen-
dent translation. The final reaction volume of 15 l con-
tained 17.5% HeLa cell extract in 20 mM HEPES-KOH pH
7.4, 135 mM KOAc, 1.1 mM Mg(OAc)2, 1.7 mM DTT,
0.16 mM spermidine, 9 M amino acids (lacking methio-
nine), 0.8 mM ATP, 0.04 mM GTP, 7.5 mM creatine phos-
phate, 20 units RNasin (Promega), 30 M methionine, and
100 ng of RNA. Reactions were incubated for 30 min at
30°C. Preincubation of HeLa S10 extract with coxsackievi-
rus protease 2A (a generous gift from R. Lloyd, Baylor
College of Medicine, Houston) was carried out at 30°C for
20 min with all of the reaction components with the excep-
tion of the RNA.
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